For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Adalimumab 40 mg or 80 mg Every Other Week (Eow) | Adalimumab 40 mg or 80 mg (same dose subject was receiving in preceding Study M03-651 \[NCT00235872\]) subcutaneously (sc) eow until approval of adalimumab in Japan | None | None | 20 | 88 | 84 | 88 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Angina pectoris | None | Cardiac disorders | None | View |
| Atrial thrombosis | None | Cardiac disorders | None | View |
| Cardiac failure | None | Cardiac disorders | None | View |
| Vertigo positional | None | Ear and labyrinth disorders | None | View |
| Cataract | None | Eye disorders | None | View |
| Enterocolitis | None | Gastrointestinal disorders | None | View |
| Ileus | None | Gastrointestinal disorders | None | View |
| Cellulitis | None | Infections and infestations | None | View |
| Enteritis infectious | None | Infections and infestations | None | View |
| Herpes zoster | None | Infections and infestations | None | View |
| Urinary tract infection | None | Infections and infestations | None | View |
| Clavicle fracture | None | Injury, poisoning and procedural complications | None | View |
| Joint dislocation | None | Injury, poisoning and procedural complications | None | View |
| Ligament rupture | None | Injury, poisoning and procedural complications | None | View |
| Tendon rupture | None | Injury, poisoning and procedural complications | None | View |
| Joint destruction | None | Musculoskeletal and connective tissue disorders | None | View |
| Knee deformity | None | Musculoskeletal and connective tissue disorders | None | View |
| Rheumatoid arthritis | None | Musculoskeletal and connective tissue disorders | None | View |
| Malignant ascites | None | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Ovarian cancer | None | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Renal failure acute | None | Renal and urinary disorders | None | View |
| Asthma | None | Respiratory, thoracic and mediastinal disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Anaemia | None | Blood and lymphatic system disorders | None | View |
| Vertigo | None | Ear and labyrinth disorders | None | View |
| Constipation | None | Gastrointestinal disorders | None | View |
| Dental caries | None | Gastrointestinal disorders | None | View |
| Diarrhoea | None | Gastrointestinal disorders | None | View |
| Abdominal pain upper | None | Gastrointestinal disorders | None | View |
| Gingivitis | None | Gastrointestinal disorders | None | View |
| Haemorrhoids | None | Gastrointestinal disorders | None | View |
| Stomatitis | None | Gastrointestinal disorders | None | View |
| Nausea | None | Gastrointestinal disorders | None | View |
| Vomiting | None | Gastrointestinal disorders | None | View |
| Adverse drug reaction | None | General disorders | None | View |
| Hepatic function abnormal | None | Hepatobiliary disorders | None | View |
| Seasonal allergy | None | Immune system disorders | None | View |
| Nasopharyngitis | None | Infections and infestations | None | View |
| Bronchitis | None | Infections and infestations | None | View |
| Upper respiratory tract infection | None | Infections and infestations | None | View |
| Pharyngitis | None | Infections and infestations | None | View |
| Tinea infection | None | Infections and infestations | None | View |
| Contusion | None | Injury, poisoning and procedural complications | None | View |
| Fall | None | Injury, poisoning and procedural complications | None | View |
| Antinuclear antibody positive | None | Investigations | None | View |
| DNA antibody positive | None | Investigations | None | View |
| Protein urine present | None | Investigations | None | View |
| Back pain | None | Musculoskeletal and connective tissue disorders | None | View |
| Rheumatoid arthritis | None | Musculoskeletal and connective tissue disorders | None | View |
| Headache | None | Nervous system disorders | None | View |
| Insomnia | None | Psychiatric disorders | None | View |
| Cough | None | Respiratory, thoracic and mediastinal disorders | None | View |
| Upper respiratory tract inflammation | None | Respiratory, thoracic and mediastinal disorders | None | View |
| Rhinorrhoea | None | Respiratory, thoracic and mediastinal disorders | None | View |
| Pharyngolaryngeal pain | None | Respiratory, thoracic and mediastinal disorders | None | View |
| Pharyngolaryngeal discomfort | None | Respiratory, thoracic and mediastinal disorders | None | View |
| Pruritus | None | Skin and subcutaneous tissue disorders | None | View |
| Rash | None | Skin and subcutaneous tissue disorders | None | View |
| Eczema | None | Skin and subcutaneous tissue disorders | None | View |
| Erythema | None | Skin and subcutaneous tissue disorders | None | View |
| Hyperkeratosis | None | Skin and subcutaneous tissue disorders | None | View |